A clinical trial to compare the combination of Lornoxicam and Paracetamol with Lornoxicam alone in relieving pain and other symptoms.

Phase 3

• Conditions: pain associated with extra articular inflammation

• Registration Number: CTRI/2009/091/000056
• Lead Sponsor: Aristo Pharmaceuticals pvt ltd Mumbai

Brief Summary

This study was comparative evaluation of a fixed dose combination of Lornoxicam & Paracetamol in short term management of mild to moderate pain in patients with extra-articular inflammation. The results shows that the combination gives better relief from pain, mobility restrictions and tenderness compared to Lornoxicam alone.

Detailed Description

Not available

Recruitment & Eligibility

• Sex: Not specified
• Target Recruitment: 201

Inclusion Criteria

• Patients with either sex, from 18-60 years age.
• Informed consent, extra articular inflammation.

Exclusion Criteria

• Female pregnant or with chances of pregnancy or nursing, History of allergy or hypersensitivity.
• physical/clinical abnormalities, any condition which affect study of drug.

Study & Design

• Study Type: Not specified
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Efficacy and safety of combination	5 days

Secondary Outcome Measures

Name	Time	Method
Tolerability and safety of the product

Trial Locations

Locations (3)

Rhushabh Nursing Home; 🇮🇳 Mumbai, MAHARASHTRA, India

Sanjeevani Medical Centre; 🇮🇳 Mumbai, MAHARASHTRA, India

Vyas Clinic; 🇮🇳 Mumbai, MAHARASHTRA, India

Rhushabh Nursing Home

🇮🇳Mumbai, MAHARASHTRA, India

Dr. Manish Shah

Principal investigator

manishhs1960@rediffmail.com